Pei Zhang Selected Research

Postoperative Hemorrhage

8/2019	Efficacy and safety of tranexamic acid usage in patients undergoing posterior lumbar fusion: a meta-analysis.
1/2018	A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery.
5/2017	Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: A meta-analysis.
4/2017	Timing of tourniquet release in total knee arthroplasty: A meta-analysis.
1/2017	Combined application versus topical and intravenous application of tranexamic acid following primary total hip arthroplasty: a meta-analysis.
12/2016	Intravenous versus topical tranexamic acid in primary total hip replacement: A meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pei Zhang Research Topics

Disease

96	Neoplasms (Cancer) 05/2022 - 02/2006
25	Infections 08/2022 - 05/2004
19	Inflammation (Inflammations) 01/2022 - 01/2015
18	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
17	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 01/2015
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 06/2014
15	Myocardial Infarction 04/2022 - 03/2002
14	Breast Neoplasms (Breast Cancer) 05/2022 - 12/2010
14	Parkinson Disease (Parkinson's Disease) 04/2022 - 12/2014
10	Hypoxia (Hypoxemia) 01/2022 - 01/2014
10	Nasopharyngeal Carcinoma 08/2020 - 11/2012
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 11/2006
8	Carcinoma (Carcinomatosis) 11/2022 - 12/2011
8	Infarction (Infarctions) 01/2015 - 03/2002
7	Wounds and Injuries (Trauma) 11/2021 - 01/2017
7	Ischemia 10/2021 - 05/2011
7	Rheumatoid Arthritis 01/2021 - 10/2016
7	Colonic Neoplasms (Colon Cancer) 01/2021 - 02/2006
7	Fibrosis (Cirrhosis) 12/2020 - 09/2012
6	Hemorrhage 01/2022 - 06/2017
6	Lung Neoplasms (Lung Cancer) 01/2020 - 04/2011
6	Carcinogenesis 01/2020 - 01/2013
6	Postoperative Hemorrhage 08/2019 - 12/2016
6	Diabetic Nephropathies (Diabetic Nephropathy) 07/2013 - 06/2006
5	Pain (Aches) 04/2022 - 03/2019
5	Adenocarcinoma of Lung 02/2022 - 10/2015
5	COVID-19 01/2022 - 10/2020
5	Atrial Fibrillation 01/2022 - 11/2017
5	Glioma (Gliomas) 09/2021 - 12/2016
5	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2017
5	Ovarian Neoplasms (Ovarian Cancer) 08/2020 - 01/2015
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2007
4	Reperfusion Injury 01/2022 - 02/2007
4	Lymphoma (Lymphomas) 01/2022 - 07/2017
4	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2018
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 12/2015
4	Stroke (Strokes) 10/2021 - 11/2017
4	Type 2 Diabetes Mellitus (MODY) 08/2021 - 09/2019
4	Arthritis (Polyarthritis) 01/2021 - 10/2016
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 03/2018
4	Lung Injury 01/2020 - 07/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 07/2016
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2016
4	Lung Diseases (Lung Disease) 01/2019 - 01/2014
4	Thrombosis (Thrombus) 01/2018 - 11/2006
4	Diabetes Mellitus 11/2016 - 06/2007
3	Ulcer 11/2022 - 01/2020
3	Human Influenza (Influenza) 07/2022 - 01/2012

Drug/Important Bio-Agent (IBA)

40	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2009
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
16	Pharmaceutical PreparationsIBA 05/2022 - 08/2005
11	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2014
10	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2004
10	Biological ProductsIBA 01/2021 - 02/2006
9	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2014
9	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 02/2012
8	Neutralizing AntibodiesIBA 01/2022 - 05/2004
8	Messenger RNA (mRNA)IBA 01/2022 - 12/2012
8	Therapeutic UsesIBA 12/2021 - 03/2010
8	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2011
8	EpitopesIBA 01/2021 - 06/2006
8	CytokinesIBA 01/2021 - 05/2014
6	Small Interfering RNA (siRNA)IBA 04/2022 - 03/2014
6	VaccinesIBA 01/2022 - 12/2009
6	Hemoglobins (Hemoglobin)IBA 08/2019 - 12/2016
5	EnzymesIBA 05/2022 - 03/2014
5	CateninsIBA 04/2022 - 01/2016
5	LigandsIBA 01/2022 - 11/2016
5	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 10/2016
5	CalciumIBA 01/2021 - 04/2013
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2016
5	CollagenIBA 01/2016 - 08/2004
4	SolutionsIBA 09/2022 - 03/2016
4	AntioxidantsIBA 01/2022 - 03/2014
4	Peptides (Polypeptides)IBA 01/2022 - 09/2012
4	Insulin (Novolin)FDA Link 01/2022 - 06/2015
4	Monoclonal AntibodiesIBA 01/2022 - 06/2006
4	Oxygen (Dioxygen)IBA 01/2022 - 05/2011
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2017
4	Neuroprotective AgentsIBA 10/2021 - 01/2018
4	ErbB Receptors (EGF Receptor)IBA 09/2021 - 09/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 11/2012
4	Phosphotransferases (Kinase)IBA 02/2021 - 03/2014
4	Long Noncoding RNAIBA 01/2021 - 12/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 06/2017
4	AntibodiesIBA 11/2020 - 01/2009
4	bromopyruvateIBA 10/2019 - 09/2013
4	Matrix Metalloproteinases (MMPs)IBA 05/2019 - 08/2004
4	UbiquitinIBA 05/2018 - 02/2016
4	Docetaxel (Taxotere)FDA Link 11/2016 - 01/2016
4	salicylhydroxamic acid (SHAM)IBA 02/2007 - 03/2002
3	HydrogelsIBA 05/2022 - 07/2021
3	Sirtuin 2IBA 04/2022 - 01/2017

Therapy/Procedure

39	Therapeutics 01/2022 - 09/2007
18	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
9	Radiotherapy 08/2020 - 01/2014
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2022 - 06/2017
6	Stents 01/2018 - 11/2006
5	Immunotherapy 01/2022 - 11/2012
5	Catheter Ablation 01/2022 - 11/2016